CBSET News
2022
2021
MD+DI: COVID-19 One Year Later: Can’t Keep a Medical Device Startup Down
Press Release: CBSET-CILcare to report experimental methodologies for performing cochlear implant studies in anatomically relevant large species at the ‘ARO 2021 Virtual Midwinter Meeting’
Cardiovascular News: FLEX Vessel Prep™ System Data Presented During Leipzig Interventional Course (LINC) 2021
Press Release: Mathieu Schué joins CILcare as Project Director of Drug Development and Translational Research
2020
Press Release: CBSET partner CILcare opens new subsidiary in Denmark
Endovascular Today: CBSET Preclinical Study Shows Balloon-Based Drug Delivery Is Critically Dependent on Coating Micromorphology
Press Release: Preclinical studies reveal balloon-based drug delivery to be critically dependent on coating micro-morphology, suggesting a paradigm for accelerated treatment optimization
Press Release: CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category
Medical Alley: COVID-19 and Quarantine – Can’t keep a medical device start-up down
Press Release: CILcare enhances its regulatory expertise with Marie-Pierre Pasdelou’s appointment as Chief Regulatory Officer
Press Release: CILcare extends its expertise to develop solutions for people with vestibular disorders with its partner Vertidiag
Press Release: CBSET Partner CILcare Promotes Dr. Cyrille Sage to Director of U.S. Operations
Press Release: CBSET partner CILcare promotes Dr. Wahid Awad to Chief Business Officer and elects him to Board of Directors
Press Release: CBSET-CILcare to report experimental methodologies for performing translational auditory research in pigs and sheep at the ‘ARO Midwinter Meeting’
2019
Press Release: CBSET’s CEO Peter Markham honored as ‘2019 Biomedical Research Business Leader’ by Massachusetts Society for Medical Research (MSMR)
Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices
Press Release: Computational model of coating and tissue morphology determinants of balloon based drug retention and tissue dosing suggest a new paradigm for accelerated treatment optimization: CBSET data published in Journal of Controlled Release
Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices
Press Release: The procedural and anatomical determinants of second-generation renal denervation therapy are explained by local tissue anatomy, suggesting a new paradigm for treatment optimization: CBSET data published in Hypertension
CRT19 Best Innovation Competition: Enhanced Plaque Modification of Cadaveric Human Calcified Peripheral Arteries Treated with a Vessel Preparation System
Not a Single Drug Is Approved to Treat Hearing Loss, but Now There Is Hope
2018
Press Release: CBSET partner CILcare leads Phase 2 of $2.1 million total DETECT project to develop a preclinical model for tinnitus drug therapy development
Press Release: Preclinical safety studies demonstrate that drug presence can accentuate pathological responses at stent fracture sites
Press Release: Study Validates New Approach for Optimizing Endovascular Drug Delivery Using Stents with a Deployable Coating That Enhances Sirolimus Distribution Compared to Traditional DES
Press Release: Preclinical safety studies must include equally balanced male/female animal models to shed light on sex-dependent vascular responses in humans
Press Release: CILcare’s age-related hearing loss model enriched with NAC as positive control
2017
Press Release: CILcare, CBSET, and Draper partner to accelerate hearing loss treatment and care
Press Release: CBSET Chairman Elazer Edelman, MD, PhD, has received the “TCT 2017 Career Achievement Award”
Press Release: Lesion Preparation Using Diamondback 360® Orbital Atherectomy System Enhances Paclitaxel Distribution in Calcified Peripheral Arteries: CBSET Data Published in Journal of Controlled Release
Endovascular Today: Lesion Preparation Using Diamondback 360 OAS Shown to Enhance Paclitaxel Distribution in Calcified PAD
Press Release: CBSET and CILcare partner to offer cutting-edge preclinical research services for the evaluation of hearing disorders and regenerative therapies
Press Release: CBSET expands its preclinical research services by adding GLP-compliant cell-based-therapies support capability
Press Release: Safety and Efficacy of New Class of Orthopedic Implant for Intramedullary Biologic Stabilization of Fractured Long Bones Studied Out to 1 Year
2016
Press Release: CBSET appoints Rami Tzafriri PhD as Director of Research and Innovation
Press Release: CBSET appoints Michael Naimark as Director of Business Development
News Advisory: You Need To Know: Endovascular Drug Delivery Is Experiencing a Resurgence in Innovation
Press Release: A Paradigm for Safety Assessment of Energy-Based Devices: CBSET Presents In Vivo Data at SoT 2016
2015
Press Release: MANTA Vascular Closure Device Safely and Effectively Closes Large Bore Arterial Access Sites: CBSET to Present Preclinical Data at ICI 2015
Press Release: Data provides new insights into the optimal balance between drug-eluting stent coating material properties and drug elution kinetics
Press Release: Primary lesion treatment using Diamondback 360® orbital atherectomy system enhances paclitaxel deposition in calcified peripheral arteries: preclinical data presented at EuroPCR 2015
Endovascular Today: Preclinical Study Evaluates Primary Lesion Treatment With CSI’s Orbital Atherectomy System Before Drug Delivery in Calcified PAD
Press Release: Roadmap for the revitalization of catheter-based renal sympathetic denervation related to clinically meaningful, optimized device design: CBSET to present compelling preclinical evidence at EuroPCR 2015
Press Release: Variable patient responses to catheter-based renal denervation therapy is explained by local tissue anatomy – suggesting a paradigm for treatment optimization: CBSET data published in Science Translational Medicine
Endovascular Today: Study Suggests That Local Tissue Anatomy May Explain Variable Patient Responses to RDN Therapy
Press Release: New Class of Orthopedic Implants for Intramedullary Biologic Fixation of Fractured Long Bones Validated in Preclinical Models – CBSET, IlluminOss Medical Data Published in Journal of Biomedical Materials Research
Press Release: Optimal tissue debulking protocol defined for treating in-stent restenosis (ISR) with Boston Scientific’s JETSTREAM® Navitus atherectomy device
Press Release: Modification of atherosclerotic plaque with Diamondback360® orbital atherectomy device improves drug uptake in peripheral arteries
2014
Press Release: Dr. Haim Danenberg joins CBSET as Chief Scientific Adviser
Press Release: Clinical Efficacy of Renal Denervation Therapies is Related to Innervation Patterns, Microanatomical Structures, and Treatment Paradigms: CBSET to Present Further Mechanistic Evidence at ‘TCT 2014’
Press Release: Efficacy of renal denervation using thermal ablation technologies is dependent on microanatomy: CBSET to present preclinical evidence at EuroPCR 2014
DAIC: CBSET Scientists Indicate Preclinical Research is Critical to the Future of Renal Denervation
Press Release: CBSET scientists indicate mechanistic preclinical research is critical to the future of renal denervation
2013
Press Release: CBSET expands capabilities for high-speed, high-resolution 3D image-guided interventions in the preclinical development of cardiovascular therapies
DAIC: CBSET Presents Preclinical Development Data on Renal Denervation Devices
Press Release: CBSET to present new paradigm at ‘TCT 2013’ for the preclinical development of renal denervation devices
PR Contact
Ron Trahan, APR
President, Ronald Trahan Associates Inc.
+1 508 816 6730
ronaldtrahan@rocketmail.com